Development of an in vitro Plasmodium parasite killing assay for the evaluation of cell-mediated immune responses following vaccination with pre-erythrocytic malaria vaccine candidates

Autor: Cm, Bliss, Am, Salman, Rhea Longley, Sm, Khan, Cj, Janse, Av, Hill, Kj, Ewer

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7aea65546443a9db82b2755a72ac231d
http://europepmc.org/abstract/PMC/PMC4179295

Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children

Autor: Bowyer G, Muhammed Afolabi, Cm, Bliss, Ab, Tiono, Drammeh A, Nébié I, Yj, Jagne, Jb, Yaro, Eb, Imoukhuede, Kl, Flanagan, Kampman B, Viebig N, Sb, Sirima, Bojang K, Av, Hill, Kj, Ewer

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2c00d4d329c913cfa0bdbedf87f8f333
http://europepmc.org/abstract/PMC/PMC4179299

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.

Autor: Datoo MS; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK., Dicko A; Clinical Research Unit of Bougouni-Ouelessebougou, Malaria Research and Training Centre, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali., Tinto H; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Ouédraogo JB; Institut des Sciences et Techniques (INSTech), Bobo-Dioulasso, Burkina Faso., Hamaluba M; Kenya Medical Research Institute Centre for Geographical Medicine Research-Coast (KEMRI-CGMRC), Kilifi, Kenya; Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, Oxford, UK., Olotu A; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Beaumont E; London School of Hygiene and Tropical Medicine, London, UK., Ramos Lopez F; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK., Natama HM; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Weston S; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK., Chemba M; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Compaore YD; Institut des Sciences et Techniques (INSTech), Bobo-Dioulasso, Burkina Faso., Issiaka D; Clinical Research Unit of Bougouni-Ouelessebougou, Malaria Research and Training Centre, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali., Salou D; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Some AM; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Omenda S; Kenya Medical Research Institute Centre for Geographical Medicine Research-Coast (KEMRI-CGMRC), Kilifi, Kenya., Lawrie A; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK., Bejon P; Kenya Medical Research Institute Centre for Geographical Medicine Research-Coast (KEMRI-CGMRC), Kilifi, Kenya., Rao H; Serum Institute of India, Pune, India., Chandramohan D; London School of Hygiene and Tropical Medicine, London, UK., Roberts R; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK., Bharati S; Serum Institute of India, Pune, India., Stockdale L; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Gairola S; Serum Institute of India, Pune, India., Greenwood BM; London School of Hygiene and Tropical Medicine, London, UK., Ewer KJ; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Bradley J; London School of Hygiene and Tropical Medicine, London, UK., Kulkarni PS; Serum Institute of India, Pune, India., Shaligram U; Serum Institute of India, Pune, India., Hill AVS; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK; The Jenner Institute Laboratories, University of Oxford, Oxford, UK. Electronic address: adrian.hill@ndm.ox.ac.uk.

Publikováno v: Lancet (London, England) [Lancet] 2024 Feb 10; Vol. 403 (10426), pp. 533-544. Date of Electronic Publication: 2024 Feb 01.

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial.

Autor: Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK., Wright D; The Jenner Institute, University of Oxford, Oxford, UK; Department of Paediatrics, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK., Platt A; The Jenner Institute, University of Oxford, Oxford, UK., Poulton I; The Jenner Institute, University of Oxford, Oxford, UK., Lawrie A; The Jenner Institute, University of Oxford, Oxford, UK., Tran N; The Jenner Institute, University of Oxford, Oxford, UK., Boyd A; The Jenner Institute, University of Oxford, Oxford, UK., Turner C; The Jenner Institute, University of Oxford, Oxford, UK., Gitonga JN; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Karanja HK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Mugo D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK., Bowden TA; Wellcome Centre for Human Genetics, Division of Structural Biology, University of Oxford, Oxford, UK., Gilbert SC; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK; Pandemic Sciences Institute, University of Oxford, Oxford, UK., Charleston B; The Pirbright Institute, Pirbright, UK., Kaleebu P; Medical Research Council-Uganda Virus Research Institute and The London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK., Warimwe GM; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya. Electronic address: gwarimwe@kemri-wellcome.org.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Aug; Vol. 23 (8), pp. 956-964. Date of Electronic Publication: 2023 Apr 13.

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.

Autor: Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Flaxman A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Aboagye J; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Bittaye M; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cappuccini F; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Charlton S; Public Health England, Porton Down, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Davies S; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Edwards NJ; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fowler J; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbride C; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert SC; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Godfrey L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Hallis B; Public Health England, Porton Down, UK., Humphries HE; Public Health England, Porton Down, UK., Jenkin D; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Sanders H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Thomas KM; Public Health England, Porton Down, UK., Ulaszewska M; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Woods D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Wright D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.

Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 2023 Mar 24; Vol. 211 (3), pp. 280-287.